LivingGLP1
parallel randomized trial

NCT01469351

Neurodegenerative Changes in Alzheimer's Disease: Identifying Potential Effects of Liraglutide on Degenerative Changes

Design

Randomized
38
Start year
2012
Treatment
26 weeks, follow-up 26 weeks
Countries
Denmark
Sponsor
University of Aarhus (mixed)
Eligibility
Alzheimer disease, MMSE 18 to 21, age above 50 and below 80, no diabetes

Conduct and analysis

Blinding
double blind
Sequence generation
other adequate
Allocation concealment
central
Outcome adjudication
not reported
Primary estimand
not stated
Analysis population
completers
Missing data
completers only

Arms

ArmTreatmentBackgroundRandomizedAnalyzedCompleted treatment
A1Placebo
Placebo
usual medication including cholinesterase inhibitors; lifestyle: not reported2018
A2Liraglutide 1.8 mg subcutaneous once daily
Liraglutide 1.8 mg
usual medication including cholinesterase inhibitors; lifestyle: not reported1813

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.
CharacteristicStatisticPlacebo
A1
Liraglutide 1.8 mg subcutaneous once daily
A2
agemax (years)80
agemean (years)66.665.4
agemin (years)50
agese (years)1.8
bmimean (kg/m2)25.125.1
bmise (kg/m2)0.71.0
femalen58
femalepercent2557
sbpmean (mmHg)149.7144.1
sbpse (mmHg)4.36.3
weightmean (kg)77.874.1
weightse (kg)3.02.1

Results

9 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Discontinuation due to adverse events (6 lines; O26)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 20not stated; randomized; R0022711:Results
A1events0 / 20not stated; randomized; R0022711:Results
A2events1 / 18not stated; randomized; R0022711:Results
A2events1 / 18not stated; randomized; cancer of the bladder; R0022711:Results
A2events1 / 18not stated; randomized; nausea and anorexia; R0022711:Results
A2events1 / 18not stated; randomized; nausea, vomiting, and fever; R0022711:Results
Discontinuation due to gastrointestinal adverse events (3 lines; O27E)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 20not stated; randomized; R0022711:Results
A2events1 / 18not stated; randomized; nausea and anorexia; R0022711:Results
A2events1 / 18not stated; randomized; nausea, vomiting, and fever; R0022711:Results